A non‐peptide NK1‐receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically
Authors:
Open Access
- 1 May 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 109 (1) , 259-264
Abstract
The non‐peptide neurokinin NK1‐receptor antagonist, RP 67580 (3aR, 7a), a perhydroisoindolone derivative, powerfully reduced plasma extravasation in rat hind paw skin induced by local application of xylene (ID50 = 0.03 mg kg−1, i.v.) or capsaicin (ID50 = 0.06 mg kg−1, i.v.), or by i.v. injection of exogenous substance P (SP) or septide ([pGlu6,Pro9]SP(6–11)) (ID50 = 0.04–0.05 mg kg−1, i.v.). RP 67580 (1 mg kg−1, i.v.) also abolished capsaicin‐induced nasal fluid hypersecretion (by 82 ± 5%). These effects were found to be stereospecific, the enantiomer, RP 68651 (3aS, 7aS), being inactive at 1 mg kg−1, i.v. In rats neonatally treated with capsaicin (50 mg kg−1, s.c.), plasma extravasation induced by SP was significantly increased (by 43 ± 7%). RP 67580 (1 mg kg−1, i.v.) completely inhibited the SP‐induced plasma extravasation in capsaicin neonatally treated‐animals, as it did in control animals. This result suggests that RP 67580 acts at the postsynaptic level for the inhibition of plasma extravasation. Opioid receptor agonists, μ‐(morphine) and κ‐(PD‐117302) at 10 mg kg−1, s.c., in contrast to NK1‐receptor antagonists, did not inhibit plasma extravasation induced by exogenous SP. They were, however, partially effective against plasma extravasation induced by electrical nerve stimulation (74 ± 4% and 48 ± 9% inhibition at 10 mg kg−1, s.c. of morphine and PD‐117302, respectively, compared to 90 ± 3% inhibition obtained with RP 67580, 3 mg kg−1, s.c.). These results indicate the presynaptic action of opioid receptor agonists, in contrast to the postsynaptic action of NK1‐preceptor antagonists for the inhibition of plasma extravasation. Ligature of the saphenous nerve distal to the point of electrical stimulation, local application of lignocaine to the saphenous nerve, neonatal capsaicin pretreatment, and colchicine at very low doses (120 μg kg−1 day−1 given for 3 days) were found to prevent plasma extravasation elicited by electrical nerve stimulation. The foregoing results demonstrate that the non‐peptide NK1‐receptor antagonist, RP67580, is a potent inhibitor of plasma extravasation induced in skin by NK1‐receptor agonists, by local application of chemical irritants (capsaicin or xylene) or by electrical nerve stimulation. Moreover, opioid receptor agonists and colchicine inhibit plasma extravasation induced by electrical nerve stimulation but not that elicited by exogenous SP. Therefore, it is possible to inhibit neurogenic inflammation either at the presynaptic level with opioid receptor agonists and colchicine, or at the postsynaptic level with NK1‐receptor antagonists, and that the new non‐peptide NK1‐receptor antagonists may have a great potential for alleviation of inflammation in various pathological syndromes in man.Keywords
This publication has 47 references indexed in Scilit:
- Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptorsJournal of Autonomic Pharmacology, 1991
- Calcitonin gene-related peptide, neurokinin A and substance P: Effects on Nociception and neurogenic inflammation in human skin and temporal musclePeptides, 1991
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991
- Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunctionLife Sciences, 1991
- Histamine application to the nasal mucosa induces release of calcitonin gene-related peptide and substance P from peripheral terminals of trigeminal ganglion: A morphological study in the guinea pigNeuroscience Letters, 1990
- The Skin as an Organ for the Study of the Pharmacology of NeuropeptidesSkin Pharmacology and Physiology, 1988
- Pharmacological receptors for substance P and neurokininsLife Sciences, 1987
- Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance PHistochemistry and Cell Biology, 1985
- Neurogenic inflammationTrends in Pharmacological Sciences, 1984
- NEUROTRANSMITTERS AND THE FIFTH CRANIAL NERVE: IS THERE A RELATION TO THE HEADACHE PHASE OF MIGRAINE?The Lancet, 1979